ArticleArchives of osteoporosis2025
Recurrent pathological fractures in chronic kidney disease revealing overlapping neglected primary hyperparathyroidism and GDF5-associated skeletal dysplasia.
Article in Archives of osteoporosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPrimary hyperparathyroidism (PHPT) is a common endocrine disorder characterized by the excessive secretion of parathyroid hormone (PTH), resulting in significant hypercalcemia and skeletal complications. In the context of chronic kidney disease (CKD), neglected PHPT can progress to a biochemical profile resembling tertiary hyperparathyroidism (THPT), further complicating diagnosis, especially when concomitant genetic skeletal disorders (GSD) exist. CASE REPORT: We present a rare and complex case of a 63-year-old woman with stage 3 CKD who presented with recurrent pathological fractures, severe hypercalcemia, and extensive osteolytic bone lesions in both femurs. The patient's clinical picture was complicated by notable skeletal anomalies, including short stature, brachydactyly, and hypoplastic metatarsals. Elevated serum calcium, markedly increased PTH levels, hypercalciuria, hyperphosphaturia, and parathyroid imaging, confirmed previously untreated PHPT resulting in a THPT-like biochemical profile in the setting of CKD. The patient ultimately underwent surgical fixation for bilateral lower limb fractures, followed by a simple parathyroidectomy, achieving symptomatic relief and metabolic stabilization. A genetic investigation, prompted by distinctive skeletal features, uncovered a frameshift mutation in the growth differentiation factor 5 (GDF5) gene indicative of brachydactyly type C, a rare form of GSD.
conclusionThis case highlights the complexity in differentiating PHPT from other causes of hyperparathyroidism in the setting of CKD, particularly when concurrent skeletal dysplasia is present. The thorough clinical, biochemical, imaging, and genetic assessments were pivotal in reaching an accurate diagnosis and guiding appropriate surgical management.
Indexed as
Identifiers
40783902What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.